background
human
metapneumoviru
hmpv
recent
detect
viru
caus
mild
sever
respiratori
tract
infect
studi
aim
detail
outcom
hmpv
infect
materialsmethod
januari
novemb
patient
hmpv
detect
nasopharyng
bronchoalveolar
lavag
molecular
respiratori
pathogen
test
evalu
food
drug
administr
clear
multiplexedpolymeras
chain
reaction
system
idaho
technolog
salt
lake
citi
ut
use
diagnosi
chest
radiographi
cr
comput
tomographi
ct
evalu
expert
radiologist
total
patient
includ
mean
age
year
male
hospit
rate
lower
respiratori
system
infect
lrti
diagnos
patient
clinic
find
patient
radiolog
find
support
diagnosi
lrti
rate
significantli
higher
adult
children
p
cr
peribronchovascular
infiltr
pi
common
featur
seen
patient
gener
bilater
patient
ct
imag
groundglass
opac
common
find
seen
patient
nodular
consolid
five
patient
ribavirin
given
four
patient
three
sever
requir
respiratori
support
none
patient
die
hmpv
infect
groundglass
opac
ct
similar
respiratori
viru
infect
pi
cr
common
typic
howev
nodular
consolid
may
mimic
bacteri
infect
seen
onefourth
ct
human
metapneumoviru
hmpv
recent
detect
viru
caus
mild
sever
respiratori
tract
infect
nodular
consolid
may
mimic
bacteri
infect
detect
one
fourth
ct
administ
patient
clinician
alert
hmpv
infect
may
present
like
bacteri
lrti
radiolog
imag
k
e
w
r
human
metapneumoviru
influenza
viru
pathogenesi
respiratori
tract
viru
classif
j
med
virol
wileyonlinelibrarycomjournaljmv
human
metapneumoviru
hmpv
defin
caus
mild
sever
respiratori
system
infect
due
increas
avail
molecular
base
test
report
hmpv
infect
increas
world
hmpv
report
one
commonli
detect
virus
caus
influenzalik
ill
communityacquir
pneumonia
adult
children
radiolog
find
hmpv
infect
report
differ
viral
pathogen
studi
high
sampl
size
howev
report
studi
includ
radiolog
find
hmpv
infect
commonli
done
among
immunocompromis
host
hmpv
infect
may
caus
fatal
patient
hematolog
malign
infect
present
wide
variat
clinic
condit
asymptomat
fatal
aim
describ
clinic
cours
diseas
detail
clinic
radiolog
find
outcom
includ
patient
inpati
outpati
depart
hmpv
nasopharyng
bronchoalveolar
lavag
diagnos
use
molecular
respiratori
pathogen
test
studi
conduct
privat
hospit
istanbul
januari
novemb
retrospect
studi
perform
review
patient
chart
clinic
featur
patient
demograph
characterist
chronic
diseas
includ
malign
disord
diabet
mellitu
chronic
kidney
liver
diseas
detail
inform
antibiot
antivir
drug
collect
chart
review
complet
blood
count
creactiv
protein
liver
kidney
function
test
studi
among
patient
bacteri
cultur
throat
sputum
blood
urin
obtain
procalcitonin
pct
studi
patient
suspicion
bacteri
infect
andor
critic
patient
chlamydia
pneumonia
mycoplasma
pneumonia
includ
multiplex
polymeras
chain
reaction
pcr
test
urin
legionella
antigen
test
perform
case
suspicion
food
drug
administr
clear
multiplexedrespiratori
pcr
system
biofirefilmarray
idaho
technolog
detect
viral
pathogen
includ
hmpv
three
bacteri
speci
use
molecular
detect
hmpv
chest
radiographi
cr
comput
tomographi
ct
done
lower
respiratori
system
infect
lrsi
suspect
radiolog
imag
patient
evalu
singl
dedic
radiologist
upper
respiratori
system
infect
ursi
defin
base
modifi
centor
score
develop
acut
tonsil
pharyng
deduc
recommend
center
diseas
control
prevent
infecti
diseas
societi
america
lrsi
defin
infecti
inflamm
lower
respiratori
tract
refer
acut
pneumonia
acut
bronchiti
acut
bronchiol
clinic
lrsi
syndrom
character
symptom
consist
respiratori
tract
infect
fever
cough
sputum
dyspnea
lung
auscult
find
crackl
rhonchu
decreas
lung
sound
radiolog
lrsi
defin
radiolog
find
lung
includ
consolid
cavit
peribronchi
groundglass
opac
ggo
airspac
consolid
small
nodul
statist
analysi
test
continu
variabl
test
comparison
categor
variabl
use
analysi
stata
statacorp
colleg
station
tx
use
p
set
signific
institut
review
board
univers
approv
studi
studi
includ
patient
figur
mean
age
patient
year
male
tabl
twothird
patient
year
old
patient
one
viru
detect
concomit
agent
follow
seven
rhinoenteroviru
five
influenza
two
coronaviru
one
respiratori
syncyti
viru
case
commonli
seen
novemb
june
case
seen
decemb
antibiot
given
patient
despit
detect
viru
rate
antibiot
prescript
higher
among
lrti
compar
ursi
p
third
gener
cephalosporin
inhibitor
combin
quinolon
commonli
use
antibiot
respect
final
ribavirin
given
four
patient
three
sever
requir
respiratori
support
none
patient
die
hmpv
infect
studi
demonstr
radiolog
find
hmpv
infect
patient
lrsi
figur
one
interest
radiolog
find
presenc
nodular
consolid
ct
gener
expect
seen
bacteri
infect
pi
cr
ggo
ct
common
radiolog
find
frequent
seen
viral
pneumonia
recent
review
radiolog
imag
viral
agent
may
caus
pneumonia
gener
radiolog
find
hmpv
infect
follow
bilater
centrilobular
nodul
ggo
multilobar
infiltr
howev
inform
nodular
consolid
addit
note
radiolog
find
hmpv
infect
commonli
report
patient
hematolog
malign
limit
data
immunocompet
patient
time
onset
symptom
hospit
admiss
may
affect
radiolog
find
studi
among
patient
normal
cr
lrsibas
clinic
find
time
onset
symptom
hospit
admiss
lower
day
p
antibiot
prescript
rate
still
high
among
patient
lrsi
confirm
antivir
treatment
hmpv
infect
ribavirin
use
hmpv
infect
limit
case
report
immunocompromis
patient
recent
studi
ribavirin
use
associ
better
clinic
outcom
report
durat
viral
shed
shorter
patient
use
ribavirin
recent
review
also
conclud
evid
recommend
ribavirin
immunocompromis
patient
fourth
european
confer
infect
leukemia
guidelin
also
comment
gener
recommend
treatment
hmpv
infect
could
made
current
evid
studi
ribavirin
use
four
case
three
sever
requir
respiratori
support
none
die
conclus
ggo
ct
similar
respiratori
viru
infect
pi
cr
common
typic
howev
nodular
consolid
may
mimic
bacteri
infect
